Structured evidence table for Curcumin Inflammatory Markers Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Curcumin Inflammatory Markers Meta-Analysis | Obesity, defined as excessive accumulation of adipose tissue, is strongly associated with metabolic complications, including hypertension, dyslipidemia, and type 2 diabetes [,]. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Curcumin Inflammatory Markers Meta-Analysis | Chronic low-grade inflammation associated with obesity contributes to metabolic dysfunction through the increased production of pro-inflammatory cytokines and adipocytokines []. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Curcumin Inflammatory Markers Meta-Analysis | 5 6 7 8 9 10 11 Studies show that obesity significantly increases the risk of chronic diseases, including type 2 diabetes, cardiovascular disease, hypertension, dyslipidemia, hyperuricemia, and insulin resistance [,]. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Curcumin Inflammatory Markers Meta-Analysis | 1 2 3 4 Metabolic disorders pose a serious challenge to healthcare systems worldwide due to their significant impact on quality of life, requiring a holistic approach in the context of prevention, diagnosis, and treatment. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Curcumin Inflammatory Markers Meta-Analysis | This escalation is strongly associated with ageing populations, obesity, sedentary lifestyles, and improved survival of diabetic patients due to advances in early detection and therapeutic management []. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Curcumin Inflammatory Markers Meta-Analysis | By reducing curcumin to nanoscale particles, these formulations significantly enhance solubility, absorption and plasma retention, resulting in improved bioavailability and therapeutic efficacy [,,,]. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Curcumin Inflammatory Markers Meta-Analysis | 22 The methodological quality of the included RCTs was evaluated using the Cochrane Risk of Bias tool, which includes seven domains included random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of data analysis, selective outcome reporting and other potential sources of bias. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Curcumin Inflammatory Markers Meta-Analysis | 1 2 1 2 3 4 5 6 7 8 Type 2 diabetes mellitus (T2DM) is a progressive and multifactorial metabolic disorder characterized by chronic hyperglycemia, insulin resistance and β‐cell dysfunction, and it accounts for nearly 90% of all diabetes cases worldwide [,]. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
Source documents